Cost effectiveness of Chlamydia trachomatis screening in Brazilian women

• Grant number: 09/18388-0
• Support Opportunities: Regular Research Grants
• Start date: July 01, 2010
• End date: June 30, 2012
• Field of knowledge: Health Sciences - Medicine - Maternal and Child Health
• Principal Investigator: Paulo César Giraldo
• Grantee: Paulo César Giraldo
• Host Institution: Centro de Atenção Integral à Saúde da Mulher (CAISM). Hospital da Mulher Professor Doutor José Aristodemo Pinotti. Universidade Estadual de Campinas (UNICAMP). Campinas , SP, Brazil
• Associated researchers: Elisa Tomazzini

Abstract

The importance of Chlamydia trachomatis infection is not only related to its high frequency, but mainly by severe repercussion on the female reproductive system. Only 30% of infected patients presented symptoms and only 40% will have a sign that could show its presence. About 70% of these cases are asymptomatic and will be not diagnosed, so there is a need of a specific program that will track patients in the time of diagnose and early treatment period. It is clear that this program does not exist in Brazil. Purpose: To evaluate the cost effectiveness of tracking Chlamydia trachomatis on sexual active women through a simulation of a tracking program that could be applied to the Brazilian population. Subjects and Methods: cost effetiveness study. The decision of tracking Chlamydia trachomatis Will be structured by a hypothetical cohort f 10.000 sexual active women with ages up to 25 years. The working time horizon will be of 10 years on the Markov model and the prevalence analysis will be made by the data revision of already published data (secondary data analysis) obtained on database, using web sites as Medline, Embase, LILACS, Cochrane Controlled Trial Register. (AU)